{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:26:14Z","timestamp":1790792774253,"version":"4.1.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R37-DA15612"],"award-info":[{"award-number":["R37-DA15612"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","award":["PACCAR Graduate Fellowship"],"award-info":[{"award-number":["PACCAR Graduate Fellowship"]}],"id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008982","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-114747"],"award-info":[{"award-number":["DGE-114747"]}],"id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003239","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:28:38Z","timestamp":1602595718000},"page":"e1003239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-6356","authenticated-orcid":true,"given":"Cora L.","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle J.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-0953","authenticated-orcid":true,"given":"Konner K.","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-8920","authenticated-orcid":true,"given":"Margaret L.","family":"Brandeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"pmed.1003239.ref001","volume-title":"UNAIDS urges countries to adopt a people-, rights- and health-centred approach to reverse the HIV epidemic among people who inject drugs","author":"United Nations AIDS Programme (UNAIDS)","year":"2016"},{"key":"pmed.1003239.ref002","unstructured":"Minton TD, Zeng Z. Jail Inmates in 2015: US Department of Justice Office of Justice Programs, Bureau of Justice Statistics; 2016 [cited 2019 Jun 5]. Available from: https:\/\/www.bjs.gov\/content\/pub\/pdf\/ji15.pdf"},{"issue":"2","key":"pmed.1003239.ref003","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jurban\/78.2.214","article-title":"Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health","volume":"78","author":"N Freudenberg","year":"2001","journal-title":"J Urban Health"},{"issue":"3","key":"pmed.1003239.ref004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1377\/hlthaff.2013.1350","article-title":"The critical link between health care and jails","volume":"33","author":"JS Marks","year":"2014","journal-title":"Health Affairs (Millwood)"},{"issue":"1","key":"pmed.1003239.ref005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/003335490512000114","article-title":"Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals","volume":"120","author":"BL Stephenson","year":"2005","journal-title":"Public Health Rep"},{"issue":"8","key":"pmed.1003239.ref006","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jama.2009.202","article-title":"Accessing antiretroviral therapy following release from prison","volume":"301","author":"J Baillargeon","year":"2009","journal-title":"JAMA"},{"key":"pmed.1003239.ref007","article-title":"Jails: Inadvertent Health Care Providers","author":"K Huh","year":"2018","journal-title":"The Pew Charitable Trusts"},{"issue":"4","key":"pmed.1003239.ref008","doi-asserted-by":"crossref","first-page":"e004666","DOI":"10.1136\/bmjopen-2013-004666","article-title":"Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study","volume":"4","author":"S Larney","year":"2014","journal-title":"BMJ Open"},{"key":"pmed.1003239.ref009","unstructured":"Maryland Department of Health and Mental Hygiene. Risk of overdose death following release from prison or jail 2014. [cited 2018 Jun 29]. Available from: https:\/\/bha.health.maryland.gov\/OVERDOSE_PREVENTION\/Documents\/corrections%20brief_V3.pdf"},{"issue":"9991","key":"pmed.1003239.ref010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial","volume":"386","author":"JD Rich","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"pmed.1003239.ref011","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study","volume":"109","author":"L Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"pmed.1003239.ref012","article-title":"Heroin deaths drop in King County, but addiction still a serious problem","author":"J Aleccia","year":"2016","journal-title":"Seattle Times"},{"issue":"6","key":"pmed.1003239.ref013","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2105\/AJPH.2012.301168","article-title":"Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36","volume":"103","author":"MD Anglin","year":"2013","journal-title":"Am J Public Health"},{"issue":"3","key":"pmed.1003239.ref014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0740-5472(02)00262-3","article-title":"Los Angeles County drug court programs: initial results","volume":"23","author":"JE Fielding","year":"2002","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"pmed.1003239.ref015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0306624X16645323","article-title":"Examining the impact of prior criminal justice history on 2-year recidivism rates: a comparison of drug court participants and program referrals","volume":"62","author":"LM Shannon","year":"2018","journal-title":"Int J Offender Ther Comp Criminol"},{"key":"pmed.1003239.ref016","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2016.08.017","article-title":"Identifying and addressing the unmet health care needs of drug court clients","volume":"71","author":"KL Dugosh","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003239.ref017","volume-title":"LEAD Program Evaluation: Describing LEAD Case Management in Participants\u2019 Own Words","author":"SL Clifasefi","year":"2016"},{"key":"pmed.1003239.ref018","volume-title":"LEAD Program Evaluation: The Impact of LEAD on Housing, Employment and Income\/Benefits","author":"SL Clifasefi","year":"2016"},{"key":"pmed.1003239.ref019","unstructured":"LEAD: Law Enforcement Assisted Diversion. About LEAD 2018. [cited 2018 Jun 29]. Available from: http:\/\/leadkingcounty.org\/about\/."},{"key":"pmed.1003239.ref020","volume-title":"LEAD Program Evaluation: Criminal Justice and Legal System Utilization and Associated Costs","author":"SE Collins","year":"2015"},{"key":"pmed.1003239.ref021","volume-title":"LEAD Program Evaluation: Recidivism Report","author":"SE Collins","year":"2015"},{"key":"pmed.1003239.ref022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.evalprogplan.2017.05.008","article-title":"Seattle's Law Enforcement Assisted Diversion (LEAD): program effects on recidivism outcomes","volume":"64","author":"SE Collins","year":"2017","journal-title":"Eval Program Plann"},{"key":"pmed.1003239.ref023","volume-title":"Results from the 2015 Washington State Drug Injector Health Survey","author":"S Kingston","year":"2016"},{"key":"pmed.1003239.ref024","volume-title":"HIV\/AIDS epidemiology report 2015","author":"S Buskin","year":"2016"},{"key":"pmed.1003239.ref025","unstructured":"Vance-Sherman A. King County profile Olympia, WA: Washington State Employment Security Department; 2015 [cited 2018 Jun 1]. Available from: https:\/\/fortress.wa.gov\/esd\/employmentdata\/reports-publications\/regional-reports\/county-profiles\/king-county-profile"},{"key":"pmed.1003239.ref026","unstructured":"Seattle and King County Public Health Department. Facts about HIV\/AIDS in incarcerated people 2009 [cited 2018 Jun 15]. Available from: http:\/\/www.kingcounty.gov\/healthservices\/health\/communicable\/hiv\/epi\/~\/media\/health\/publichealth\/documents\/hiv\/HIVIncarcerated.ashx"},{"issue":"8","key":"pmed.1003239.ref027","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1017\/S0950268815003180","article-title":"Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs","volume":"144","author":"JF Monteiro","year":"2016","journal-title":"Epidemiol Infect"},{"key":"pmed.1003239.ref028","unstructured":"University of Washington. Hepatitis C online 2017. [cited 2018 Apr 3]. Available from: http:\/\/www.hepatitisc.uw.edu\/."},{"issue":"2","key":"pmed.1003239.ref029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/M14-0404","article-title":"Breaking the silence on viral hepatitis","volume":"161","author":"RO Valdiserri","year":"2014","journal-title":"Ann Intern Med"},{"key":"pmed.1003239.ref030","volume-title":"HIV\/AIDS epidemiology report, first half 2013","author":"S Buskin","year":"2013"},{"key":"pmed.1003239.ref031","unstructured":"Berk Consulting. Analysis of Statewide Adult Correctional Needs and Costs. Final Report Submitted to the Office of Financial Management, November 6, 2014. Washington State. 2014 [cited 2018 Jun 29]. Available from: http:\/\/www.ofm.wa.gov\/reports\/Correctional_Needs_and_Costs_Study2014.pdf"},{"key":"pmed.1003239.ref032","unstructured":"Washington State Office of Financial Management. Prison inmate population Seattle, Washington: The State of Washington; 2017 [updated January 9, 2017; cited 2018 Jun 29]. Available from: http:\/\/www.ofm.wa.gov\/trends\/budget\/fig408.asp"},{"key":"pmed.1003239.ref033","volume-title":"Behind Bars II: Substance Abuse and America\u2019s Prison Population","author":"The National Center on Addiction and Substance Abuse at Columbia University","year":"2010"},{"key":"pmed.1003239.ref034","unstructured":"Washington State Department of Corrections. Average daily population of incarcerated individuals, fiscal year 2017 2017 [cited 2020 Sep 26]. Available from: https:\/\/www.doc.wa.gov\/docs\/publications\/reports\/400-RE002-1906.pdf"},{"key":"pmed.1003239.ref035","unstructured":"Washington State Department of Corrections. Washington State prisons. March 2016. 2016 [cited 2020 Sep 26]. Available from: https:\/\/doc.wa.gov\/corrections\/incarceration\/prisons\/default.htm\/."},{"key":"pmed.1003239.ref036","unstructured":"Washington State Department of Corrections. Number of prison admissions by county of admission. August 2015. 2015 [cited 2020 Sep 26]. Available from: https:\/\/www.doc.wa.gov\/docs\/publications\/reports\/200-RE001.pdf"},{"key":"pmed.1003239.ref037","unstructured":"King County Department of Adult and Juvenile Detention. Detention and alternatives report 2015 [cited 2018 Jun 29]. Available from: http:\/\/www.kingcounty.gov\/~\/media\/courts\/detention\/documents\/KC_DAR_12_2015.ashx?la=en"},{"issue":"1","key":"pmed.1003239.ref038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/OLQ.0b013e3181453a84","volume":"35","author":"DT Hamilton","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"15","key":"pmed.1003239.ref039","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archinternmed.2010.249","article-title":"Comparative effectiveness of HIV testing and treatment in highly endemic regions","volume":"170","author":"E Bendavid","year":"2010","journal-title":"Arch Intern Med"},{"key":"pmed.1003239.ref040","unstructured":"Public Health Agency of Canada. HIV transmission risk: A summary of the evidence 2012 [cited 2018 Jun 29]. Available from: http:\/\/www.catie.ca\/sites\/default\/files\/HIV-TRANSMISSION-RISK-EN.pdf"},{"issue":"2","key":"pmed.1003239.ref041","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1360-0443.2011.03618.x","article-title":"Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration","volume":"107","author":"S Larney","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"pmed.1003239.ref042","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M15-2634","article-title":"Cost-effectiveness of HIV preexposure prophylaxis for people who inject drugs in the United States","volume":"165","author":"CL Bernard","year":"2016","journal-title":"Ann Intern Med"},{"issue":"5","key":"pmed.1003239.ref043","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/00952990802146340","article-title":"Drug treatment outcomes for persons on waiting lists","volume":"34","author":"J Chun","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"pmed.1003239.ref044","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/002204260603600404","article-title":"Waiting time as a barrier to treatment entry: perceptions of substance users","volume":"36","author":"C Redko","year":"2006","journal-title":"J Drug Issues"},{"issue":"5","key":"pmed.1003239.ref045","doi-asserted-by":"crossref","first-page":"e1002312","DOI":"10.1371\/journal.pmed.1002312","article-title":"Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis","volume":"14","author":"CL Bernard","year":"2017","journal-title":"PLoS Med"},{"issue":"12","key":"pmed.1003239.ref046","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/oxfordjournals.aje.a116962","article-title":"Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users","volume":"139","author":"EJ van Ameijden","year":"1994","journal-title":"Am J Epidemiol"},{"issue":"2","key":"pmed.1003239.ref047","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0376-8716(01)00200-9","article-title":"High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study","volume":"66","author":"CM Fuller","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"pmed.1003239.ref048","first-page":"1","article-title":"United States life tables, 2010","volume":"63","author":"E Arias","year":"2014","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"pmed.1003239.ref049","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-156-4-201202210-00005","article-title":"New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis","volume":"156","author":"S Liu","year":"2012","journal-title":"Ann Intern Med"},{"issue":"17","key":"pmed.1003239.ref050","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/archinternmed.2008.1","article-title":"Cost-effectiveness of HIV monitoring strategies in resource-limited settings\u2013a Southern African analysis","volume":"168","author":"E Bendavid","year":"2008","journal-title":"Arch Intern Med"},{"key":"pmed.1003239.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09540121.2020.1719966","article-title":"Clinical outcomes and cost-effectiveness of treating depression in HIV-infected populations in sub-Saharan Africa: a model-based analysis","volume":"20","author":"H Zhong","year":"2020","journal-title":"AIDS Care"},{"key":"pmed.1003239.ref052","unstructured":"National Institute on Drug Abuse. Overdose death rates, revised 2017 2017 [cited 2018 Jun 29]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"issue":"1","key":"pmed.1003239.ref053","first-page":"66","article-title":"Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland's public health policy evaluation, and a new measure to assess impact","volume":"22","author":"SM Bird","year":"2015","journal-title":"Drugs (Abingdon Engl)"},{"issue":"6","key":"pmed.1003239.ref054","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"JD Lee","year":"2015","journal-title":"Addiction"},{"issue":"12","key":"pmed.1003239.ref055","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1513\/AnnalsATS.201701-022OC","article-title":"The critical care crisis of opioid overdoses in the United States","volume":"14","author":"JP Stevens","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"pmed.1003239.ref056","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1360-0443.2003.00474.x","article-title":"The ratio of non-fatal to fatal heroin overdose","volume":"98","author":"S Darke","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"pmed.1003239.ref057","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/15564880802612615","article-title":"Evidence-based public policy options to reduce crime and criminal justice costs: implications in Washington State","volume":"4","author":"EK Drake","year":"2009","journal-title":"Victims & Offenders"},{"issue":"1","key":"pmed.1003239.ref058","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices\u2014Modeling Studies","volume":"6","author":"MC Weinstein","year":"2003","journal-title":"Value Health"},{"issue":"10","key":"pmed.1003239.ref059","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"GD Sanders","year":"2016","journal-title":"JAMA"},{"issue":"Suppl 1","key":"pmed.1003239.ref060","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/QAI.0b013e3181f9c203","article-title":"Towards a comprehensive approach to HIV prevention for people who use drugs","volume":"55","author":"BDL Marshall","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"pmed.1003239.ref061","doi-asserted-by":"crossref","first-page":"e45176","DOI":"10.1371\/journal.pone.0045176","article-title":"Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users","volume":"7","author":"LE Cipriano","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"pmed.1003239.ref062","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","article-title":"Modeling good research practices\u2014overview: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20141","volume":"15","author":"JJ Caro","year":"2012","journal-title":"Value Health"},{"issue":"4","key":"pmed.1003239.ref063","first-page":"399","article-title":"Structural sensitivity in HIV modeling: a case study of vaccination","volume":"2","author":"CL Bernard","year":"2017","journal-title":"Infect Dis Model"},{"issue":"2","key":"pmed.1003239.ref064","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/21505594.2015.1085151","article-title":"Modeling hepatitis C virus transmission among people who inject drugs: assumptions, limitations and future challenges","volume":"7","author":"N Scott","year":"2016","journal-title":"Virulence"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:29:29Z","timestamp":1602595769000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003239"}},"subtitle":[],"editor":[{"given":"Alexander C.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003239","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}